Etoposide, methotrexate, and bleomycin in drug-resistant gestational trophoblastic disease
- 1 May 1986
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 24 (1) , 51-57
- https://doi.org/10.1016/0090-8258(86)90007-7
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Use of oral VP16-213 as primary chemotherapeutic agent in treatment of gestational trophoblastic diseaseAmerican Journal of Obstetrics and Gynecology, 1984
- Reevaluation of 5-fluorouracil as a single therapeutic agent for gestational trophoblastic neoplasmsAmerican Journal of Obstetrics and Gynecology, 1984
- Intensive inpatient therapy and survival in gestational trophoblastic diseaseGynecologic Oncology, 1983
- Anti-tumour activity of the epipodophyllin derivative VP16–213 (etoposide: NSC-141540) in gestational choriocarcinomaPublished by Elsevier ,1980
- Activity of high-dose cis-platinum (NCI 119875) in combination with vincristine and methotrexate in drug-resistant gestational choriocarcinoma. A report of 17 casesBritish Journal of Cancer, 1979
- Risk and prognostic factors in trophoblastic neoplasiaCancer, 1976
- THE PATHOLOGY OF CHORIOCARCINOMAAnnals of the New York Academy of Sciences, 1971
- Treatment of leukemia with large doses of methotrexate and folinic acid: clinical-biochemical correlatesJournal of Clinical Investigation, 1969
- Long-Term Remissions in Childhood Acute LeukemiaClinical Pediatrics, 1966